Using question prompts to help breast cancer patients before chemotherapy
Question Prompt List as a Tool to Promote Patient-physician Concordance in the Understanding of Information on Neoadjuvant Treatment in Breast Cancer: a Randomized Controlled Trial
NA · Region Örebro County · NCT06777420
This study is testing whether a list of questions can help breast cancer patients feel more informed and less anxious before starting chemotherapy.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 218 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Region Örebro County (other) |
| Drugs / interventions | chemotherapy |
| Locations | 3 sites (Uppsala, Region Uppsala and 2 other locations) |
| Trial ID | NCT06777420 on ClinicalTrials.gov |
What this trial studies
This study aims to improve communication between healthcare providers and breast cancer patients who are planning to undergo neoadjuvant chemotherapy. It utilizes a question prompt list (QPL) to facilitate better information exchange, helping patients understand their treatment options and make informed decisions. By addressing the complexities of preoperative treatment discussions, the study seeks to reduce patient anxiety and enhance shared decision-making. The effectiveness of the QPL in this context will be evaluated to determine its impact on patient understanding and satisfaction.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with operable early-stage breast cancer who are eligible for systemic neoadjuvant therapy.
Not a fit: Patients with locally advanced breast cancer requiring mandatory neoadjuvant therapy or those with cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could empower patients with better information and reduce anxiety during the decision-making process regarding their treatment.
How similar studies have performed: Previous studies have shown that question prompt lists can enhance patient-physician communication in various medical contexts, indicating potential success for this approach in breast cancer treatment discussions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with operable breast cancer eligible for systemic neoadjuvant therapy, according to current treatment guidelines. Exclusion Criteria: * Patients with locally advanced breast cancer where neoadjuvant therapy is mandatory rather than a treatment option. * Patients with cognitive impairment that are assessed from treating physician as unable to participate. * Patients who cannot speak/read neither Swedish nor English.
Where this trial is running
Uppsala, Region Uppsala and 2 other locations
- Akademiska Uppsala University Hospital — Uppsala, Region Uppsala, Sweden (NOT_YET_RECRUITING)
- Västerås General Hospital — Västerås, Region Västmanland, Sweden (NOT_YET_RECRUITING)
- Örebro University Hospital — Örebro, Sweden (RECRUITING)
Study contacts
- Principal investigator: Antonis Valachis, MD, PhD — Department of Oncology, Örebro University Hospital, Sweden
- Study coordinator: Antonios Valachis, MD, PhD
- Email: antonios.valachis@regionorebrolan.se
- Phone: +46 0196021792
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Breast Cancer Early Stage Breast Cancer, Neoadjuvant Therapy, Shared Decision Making, breast cancer, neoadjuvant therapy, question prompt list, patient-physician communication, shared decision making